Advanced Medical Technology Corporation (amt)
Essay Preview: Advanced Medical Technology Corporation (amt)
Report this essay
Advanced Medical Technology Corporation (AMT)Case Write-up Guidelines/SuggestionsBackground AnalysisWhat has created the need for additional financing by AMT over the past few years? What are some of AMT’s most important financial characteristics over this period?How much will AMT need to borrow by yearend 1988? Management has given you its financial forecast, as follows. You may also want to do your own assessment of what you expect their results to be by forecasting their income statement and balance sheet, based on an analysis of their recent trends. Management Forecasts (millions) 1986 1987 1988 Sales (+35% per year) $41.6 $56.2 $75.9 Profits after tax .4 2.8 4.6 After tax profits % of sales .96% 5.0% 6.1%
In addition, due to the new computer inventory management system, they expect the inventory turnover ratio to improve to 2 times in 1986 – 1988, vs. its current level.How effective has Mr. Haskins been in managing his banking relationships?Do you believe Biological Labs will support AMT if AMT has financial difficulties? (See their financials attached.)WriteupAs credit analysts, write a memo to Tom Winter with your recommendation as to whether or not Western National should extend credit to AMT. Support your recommendation by incorporating your answers to the above questions in your memo and appendices. If you do recommend a loan to AMT, provide details on how you would structure the financing.Financial Summary, Biological Labs, 1981-198519811982198319841985Sales ($MM)2,3432,6022,9283,1043,360Net income: ($MM)247289348403465 % sales10.511.111.913.013.8 % equity21.522.124.525.124.9Per shareEPS$1.01$1.19$1.43$1.67$1.94Dividend$.35$.41$.58$.58$.68Market price$12-16$13-21$18-27$18-24$20-36P/E ratio1414161314Balance Sheet Capitalization at 12/31/1985Book Values ($MM)Market Values ($MM)Long-term debt443Long-term debt397Deferred taxes252Deferred taxes252Equity1,871Equity7,2462,5667,895(Note – 240 million total common shares outstanding)